menu
    • menu

    Company profile for Daré Bioscience

    NEW Drugs in Dev: 14
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Daré Bioscience is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women’s health. The company’s mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health, sexual health, and fertility.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Daré BioscienceUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3655 Nobel Drive, Suite 260, San Diego, CA 92122
    Telephone
    Telephone
    858.926.7655
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://darebioscience.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/dare-bioscience/?viewAsMember=true
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/DareBioscience

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Daré Bio Joins Virtual Investor “What This Means” Segment
    Daré Bio Joins Virtual Investor “What This Means” Segment

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3254546/30757/en/Dar%C3%A9-Bioscience-Participates-in-Virtual-Investor-What-This-Means-Segment.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Daré Bioscience Regains Ovaprene Rights, Shares Phase 3 Update
    Daré Bioscience Regains Ovaprene Rights, Shares Phase 3 Update

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3196959/30757/en/Dar%C3%A9-Bioscience-Announces-Return-of-Rights-to-Ovaprene-Phase-3-Program-Ongoing-Positive-Interim-Data-and-Grant-Funding-Position-Asset-for-Value-Maximization.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Daré Bioscience Receives $3.6 Million In Additional Grant Funding
    Daré Bioscience Receives $3.6 Million In Additional Grant Funding

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193460/30757/en/Dar%C3%A9-Bioscience-Receives-3-6-Million-in-Additional-Grant-Funding.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Daré Bioscience Reports Q3 2025 Financials And Corporate Update
    Daré Bioscience Reports Q3 2025 Financials And Corporate Update

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187798/30757/en/Dar%C3%A9-Bioscience-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Daré Bioscience Prepares For DARE To PLAY Sildenafil Cream
    Daré Bioscience Prepares For DARE To PLAY Sildenafil Cream

    11 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/11/3185370/30757/en/Dar%C3%A9-Bioscience-Highlights-Commercial-Launch-Readiness-for-DARE-to-PLAY-Sildenafil-Cream-November-17th-Webinar-to-Feature-Leading-Clinicians-Discussing-Clinical-Data-and-Potential-.html

    GLOBENEWSWIRE
    11 Nov 2025
    Share Share
    Daré Bio To Host Q3 2025 Financial Results Conference Call
    Daré Bio To Host Q3 2025 Financial Results Conference Call

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3182483/30757/en/Dar%C3%A9-Bioscience-to-Host-Third-Quarter-2025-Financial-Results-and-Company-Update-Conference-Call-and-Webcast-on-November-13-2025.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search